Correlation of VEGF production with IL1α and IL6 secretion by human pituitary adenoma cells

被引:32
作者
Borg, SA
Kerry, KE
Royds, JA
Battersby, RD
Jones, TH
机构
[1] Univ Sheffield, Sch Med, Hormone & Vasc Grp, Acad Unit Endocrinol,Div Genom Med, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Otago, Dept Pathol, Otago, New Zealand
[3] Royal Hallamshire Hosp, Dept Neurosurg, Sheffield S10 2RX, S Yorkshire, England
[4] Barnsley Dist Gen Hosp, Ctr Diabet & Endocrinol, Barnsley S75 2EP, England
关键词
D O I
10.1530/eje.1.01843
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Vascular endothelial growth factor (VEGF) is considered to be the most important angiogenic factor involved in the neovascularisation of solid tumours. Regulatory molecules include cytokines and growth factors. Interleukin (IL)1 and IL6 have both been shown to regulate VEGF levels in a variety of tissues. The role of cytokines in the pathogenesis of pituitary tumours remains unclear. We have examined the expression of VEGF and its relationships with IL1 and IL6 in the human pituitary tumour cell line HP75 and a series of human pituitary tumours. We have also looked at the relationship of tumour volume and invasive status to VEGF secretion. Methods: Surgically resected tumours were routinely cultured in single-cell suspension at 200 K/well (standard unit for culture of dispersed primary pituitary adenoma cells). We measured VEGF, IL1alpha and IL6 levels by ELISA. Tumour volume and invasion grade were assessed by preoperative magnetic resonance imaging. Results: VEGF was detected in conditioned medium of HP75 cells (900 +/- 52 pg/ml) and in 82% of tumours tested (range 2 6 - 16 4 64 pg/ml). Tumour volume and secretion of VEGF were significantly associated with levels of IL6 (volume, P = 0.056; VEGF, P < 0.001 (P values based on Spearman's test)) and IL1alpha produced (volume, P < 0.005; VEGF, P < 0.001). Invasive tumours showed a higher basal secretion of VEGF that that of the non-invasive type; however, this difference was not significant. Addition of exogenous IL1alpha, but not IL6, significantly increased VEGF production. Conclusions: The significant associations between VEGF and the levels of IL6 and IL1alpha suggest an important role for these cytokines in the development of these tumours.
引用
收藏
页码:293 / 300
页数:8
相关论文
共 51 条
[1]  
Atkin S. L., 1995, In Vitro Cellular and Developmental Biology Animal, V31, P657, DOI 10.1007/BF02634085
[2]   KERATINOCYTES AS INITIATORS OF INFLAMMATION [J].
BARKER, JNWN ;
MITRA, RS ;
GRIFFITHS, CEM ;
DIXIT, VM ;
NICKOLOFF, BJ .
LANCET, 1991, 337 (8735) :211-214
[3]   INDUCTION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION IN SYNOVIAL FIBROBLASTS BY PROSTAGLANDIN-E AND INTERLEUKIN-1 - A POTENTIAL MECHANISM FOR INFLAMMATORY ANGIOGENESIS [J].
BENAV, P ;
CROFFORD, LJ ;
WILDER, RL ;
HLA, T .
FEBS LETTERS, 1995, 372 (01) :83-87
[4]  
Benoy Ina, 2002, Clin Breast Cancer, V2, P311, DOI 10.3816/CBC.2002.n.008
[5]   Expression of interleukin-6 and its effects on growth of HP75 human pituitary tumor cells [J].
Borg, SA ;
Kerry, KE ;
Baxter, L ;
Royds, JA ;
Jones, TH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (10) :4938-4944
[6]   EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) AND ITS RECEPTORS IN BREAST-CANCER [J].
BROWN, LF ;
BERSE, B ;
JACKMAN, RW ;
TOGNAZZI, K ;
GUIDI, AJ ;
DVORAK, HF ;
SENGER, DR ;
CONNOLLY, JL ;
SCHNITT, SJ .
HUMAN PATHOLOGY, 1995, 26 (01) :86-91
[7]  
BROWN LF, 1997, EXS, V79, P233
[8]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[9]   Interleukin 6 induces the expression of vascular endothelial growth factor [J].
Cohen, T ;
Nahari, D ;
Cerem, LW ;
Neufeld, G ;
Levi, BZ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :736-741
[10]   Tumor angiogenesis [J].
Detmar, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2000, 5 (01) :20-23